
HTG Molecular Diagnostics HTGM
Annual report 2022
added 03-30-2023
HTG Molecular Diagnostics Total Inventories 2011-2026 | HTGM
Annual Total Inventories HTG Molecular Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 909 K | 1.99 M | 1.49 M | 1.27 M | 1.31 M | 1.18 M | 1.51 M | 2.2 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.2 M | 909 K | 1.48 M |
Quarterly Total Inventories HTG Molecular Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 1.69 M | 1.96 M | 2.02 M | 1.99 M | 2.34 M | 2.32 M | 1.6 M | 1.49 M | 1.49 M | 1.49 M | 1.49 M | 1.27 M | 1.27 M | 1.27 M | 1.27 M | 1.31 M | 1.31 M | 1.31 M | 1.31 M | 1.18 M | 1.18 M | 1.18 M | 1.18 M | 1.51 M | 1.51 M | 1.51 M | 1.51 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 1.69 M | 1.69 M | 1.69 M | 1.69 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.34 M | 1.18 M | 1.61 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aspira Women's Health
AWH
|
316 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | ||
|
Burning Rock Biotech Limited
BNR
|
123 M | $ 34.5 | 2.16 % | $ 371 M | ||
|
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | ||
|
BioNano Genomics
BNGO
|
13.3 M | $ 1.29 | -12.26 % | $ 1.64 M | ||
|
Castle Biosciences
CSTL
|
8.14 M | $ 39.74 | 1.48 % | $ 1.1 B | ||
|
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
1.66 M | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
2.33 B | $ 219.29 | -0.08 % | $ 160 B | ||
|
Exact Sciences Corporation
EXAS
|
162 M | $ 102.41 | 0.1 % | $ 19 B | ||
|
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | ||
|
Guardant Health
GH
|
71.1 M | $ 113.17 | 2.43 % | $ 13.9 B | ||
|
DexCom
DXCM
|
560 M | $ 73.31 | -0.93 % | $ 28.3 B | ||
|
CareDx, Inc
CDNA
|
19.5 M | $ 20.55 | -1.23 % | $ 1.1 B | ||
|
DarioHealth Corp.
DRIO
|
5.06 M | $ 10.2 | -0.97 % | $ 289 M | ||
|
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | ||
|
Lantheus Holdings
LNTH
|
68 M | $ 66.91 | 0.34 % | $ 4.63 B | ||
|
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | ||
|
Illumina
ILMN
|
547 M | $ 144.81 | -3.26 % | $ 23 B | ||
|
NeoGenomics
NEO
|
26.7 M | $ 11.99 | -3.35 % | $ 1.52 B | ||
|
QIAGEN N.V.
QGEN
|
279 M | - | - | $ 10.6 B | ||
|
Charles River Laboratories International
CRL
|
279 M | $ 210.51 | -0.59 % | $ 10.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
188 M | $ 186.45 | 2.27 % | $ 20.7 B | ||
|
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
384 K | $ 24.07 | -0.78 % | $ 31.2 M | ||
|
Laboratory Corporation of America Holdings
LH
|
493 M | $ 271.34 | 0.56 % | $ 22.8 B | ||
|
Mettler-Toledo International
MTD
|
342 M | $ 1 370.47 | -1.61 % | $ 29.1 B | ||
|
ICON Public Limited Company
ICLR
|
2.3 M | $ 181.44 | -2.39 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
382 M | $ 672.84 | -0.57 % | $ 55.5 B | ||
|
Agilent Technologies
A
|
830 M | $ 133.33 | 0.07 % | $ 40.5 B | ||
|
Biomerica
BMRA
|
1.49 M | $ 2.41 | 0.84 % | $ 5.54 M |